Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Ixabepilone-sunitinib combination holds potential against chemotherapy-resistant ovarian cancer

The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.

8 Dec 2011

Genetic variation predicts survival chances of ovarian cancer

Yale Cancer Center researchers have shown that a tiny genetic variation predicts chances of survival and response to treatment for patients with ovarian cancer.

5 Dec 2011

P-Rex1 gene plays a key role in the spread of malignant melanoma

SCIENTISTS in Glasgow have made an important discovery in the fight against malignant melanoma, the most dangerous form of skin cancer.

5 Dec 2011

Advaxis completes ADXS-HER2 pre-IND meeting with FDA

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, completed a pre-IND meeting with the FDA on November 22, 2011 to discuss the development plan for ADXS-HER2, an immunotherapy for the treatment of HER2 expressing cancers.

23 Nov 2011

Study reveals PEA-15 protein can enhance cancer cell proliferation

A new study from the University of Hawaii Cancer Center reveals that PEA-15, a protein previously shown to slow ovarian tumor growth and metastasis, can alternatively enhance tumor formation in kidney cells carrying a mutation in a cancer-promoting gene called H-Ras.

22 Nov 2011

Cancer Research UK initiates recruitment for Stratified Medicine Programme

Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.

21 Nov 2011

Tikcro reports net loss of $1.0 million for third quarter 2011

Tikcro Technologies Ltd. today reported results for the third quarter and nine months ended September 30, 2011.

18 Nov 2011

Potential breakthrough in treating late-stage ovarian cancer

A potential breakthrough in treating late-stage ovarian cancer has come from University of Guelph researchers who have discovered a peptide that shrinks advanced tumours and improves survival rates for this deadly but often undetected disease.

17 Nov 2011

Cancer drug joins list of medicines in short supply

A crucial cancer drug has been in short supply since midsummer - and its maker, Johnson & Johnson Inc., has not been able to remedy the situation since.

14 Nov 2011

EntreMed third quarter net loss decreases to $1.3 million

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and nine-month periods ending September 30, 2011.

14 Nov 2011

First Edition: November 14, 2011

In today's headlines, reports about the Supreme Court's expected health law announcement; about where things stand with the super committee and its fast-approaching deadline; and other health policy news.

14 Nov 2011

Access partners to exploit CobaCyte and CobOral technology for targeted RNAi therapeutic delivery

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major player in RNAi industry to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.

9 Nov 2011

New breast and ovarian cancer vaccine in the pipeline: Study

A new vaccine is being tried clinically to combat tumor cells in a small study of advanced breast and ovarian cancer patients. The results show that there is improvement in overall survival times and stopping the disease for a handful of breast cancer patients.

8 Nov 2011

Perry's health benefits noted; Romney and Perry spar on immigrants and health care

Texas Gov. Rick Perry is entitled to a lucrative pension from his government job that includes lifetime health care paid for by the state, The Texas Tribune reports. Meanwhile, Perry and former Mass. Gov. Mitt Romney exchanged barbs about their records.

8 Nov 2011

EpiCept reports net loss of $5.4 million for third quarter 2011

EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2011, and provided an update with respect to the Company's key business initiatives.

8 Nov 2011

Just couple of glasses of wine a day could raise risk of breast cancer: Study

According to a new major study just two glasses of a wine a day can increase the risk of breast cancer among women by 50%. Researchers also warn that women who drink regularly in their 20s and 30s are far more likely to develop breast cancer in later life, regardless of whether they reduce their alcohol consumption.

7 Nov 2011

Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven by the launches of several promising emerging therapies, the prostate cancer drug market will experience robust growth over the next decade, increasing from $3.6 billion in 2010 to $10.1 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

7 Nov 2011

Blocking APE1 enzyme could provide new way to kill cancer cells

BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.

7 Nov 2011

Sitting around could be waiting for cancer to strike say researchers

A new analysis reveals that more than 90,000 new cancer cases a year in the United States may be due to physical inactivity and prolonged periods of sitting. The researchers presented their findings at the annual conference of the American Institute for Cancer Research (AICR) in Washington, D.C., citing about 49,000 cases of breast cancer and 43,000 of colon cancer from over 200 studies worldwide.

6 Nov 2011

Cancer drug shortage relates to economics

A perspective in this week's New England Journal of Medicine outlines this connection. Meanwhile, a House Democrat ramps up his investigation into the "gray market" and how it is contributing to the shortage.

4 Nov 2011

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Ixabepilone-sunitinib combination holds potential against chemotherapy-resistant ovarian cancer

Genetic variation predicts survival chances of ovarian cancer

P-Rex1 gene plays a key role in the spread of malignant melanoma

Advaxis completes ADXS-HER2 pre-IND meeting with FDA

Study reveals PEA-15 protein can enhance cancer cell proliferation

Cancer Research UK initiates recruitment for Stratified Medicine Programme

Tikcro reports net loss of $1.0 million for third quarter 2011

Potential breakthrough in treating late-stage ovarian cancer

Cancer drug joins list of medicines in short supply

EntreMed third quarter net loss decreases to $1.3 million

First Edition: November 14, 2011

Access partners to exploit CobaCyte and CobOral technology for targeted RNAi therapeutic delivery

New breast and ovarian cancer vaccine in the pipeline: Study

Perry's health benefits noted; Romney and Perry spar on immigrants and health care

EpiCept reports net loss of $5.4 million for third quarter 2011

Just couple of glasses of wine a day could raise risk of breast cancer: Study

Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020

Blocking APE1 enzyme could provide new way to kill cancer cells

Sitting around could be waiting for cancer to strike say researchers

Cancer drug shortage relates to economics

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in